Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Fluorometholone · Flarex, Fml

Small molecule · developed by Abbvie

Approved FDA, Jan 1972
1 Registered trials

What is Fluorometholone?

Fluorometholone is a topical ophthalmic suspension, 0.1%, used as an eye drop.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Flarex, Fml, Fml Forte, NSC-33001
Drug type
Small molecule
Therapy area
Ophthalmology
Developer
Abbvie
In trials of
HROW
FDA status
Approved as Flarex, Fml, Fml Forte (January 12, 1972), NDA016851 · FDA label
UNII
SV0CSG527L

✅ FDA-approved uses

From the indications section of the FDA label (version of Mar 31, 2025). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT07588074 Phase 4 Ocular Inflammation Completed HROW

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Dry Eye Disease (DED)Dry Eye SyndromesKerato Conjunctivitis SiccaKeratoconjunctivitisOcular InflammationPost-operative ComplicationsPostoperative Complications

Sources

Updated Oct 18, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.